HCA Healthcare (NYSE:HCA) EVP Sells $1,606,670.24 in Stock

Key Points

• HCA Healthcare EVP Michael Cuffe sold 3,836 shares of stock for a total of $1,606,670.24, resulting in a 10.85% decrease in his position.
• The company reported quarterly earnings with an EPS of $6.84, surpassing analysts' expectations, and had a revenue of $18.61 billion for the same period.
• HCA Healthcare announced a quarterly dividend of $0.72 per share, with a payout ratio of 12.11%, set to be paid on September 30th.

HCA Healthcare, Inc. (NYSE:HCA - Get Free Report) EVP Michael Cuffe sold 3,836 shares of the stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the transaction, the executive vice president directly owned 31,503 shares of the company's stock, valued at $13,194,716.52. This trade represents a 10.85% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

HCA Healthcare Trading Down 0.7%

Shares of HCA Healthcare stock traded down $2.82 on Monday, reaching $417.95. 1,472,775 shares of the company's stock were exchanged, compared to its average volume of 1,056,520. The company has a market capitalization of $97.80 billion, a P/E ratio of 17.13, a price-to-earnings-growth ratio of 1.32 and a beta of 1.41. The firm's 50-day moving average is $380.14 and its two-hundred day moving average is $360.39. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $420.98. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The business had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. During the same period last year, the company posted $5.50 earnings per share. HCA Healthcare's quarterly revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be given a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is presently 12.11%.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on HCA shares. JPMorgan Chase & Co. increased their price objective on shares of HCA Healthcare from $360.00 to $370.00 and gave the company a "neutral" rating in a report on Monday, August 4th. Morgan Stanley cut their price target on shares of HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating on the stock in a report on Monday, July 28th. Wells Fargo & Company lowered their target price on shares of HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating for the company in a research note on Thursday, August 14th. Royal Bank Of Canada dropped their target price on shares of HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating on the stock in a research note on Monday, July 28th. Finally, Wolfe Research cut HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research note on Monday, July 28th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat, HCA Healthcare has an average rating of "Moderate Buy" and a consensus price target of $401.83.

Institutional Investors Weigh In On HCA Healthcare

Institutional investors and hedge funds have recently modified their holdings of the company. Cheviot Value Management LLC acquired a new stake in HCA Healthcare during the first quarter worth approximately $26,000. Saudi Central Bank purchased a new position in shares of HCA Healthcare in the first quarter valued at $26,000. WPG Advisers LLC acquired a new stake in HCA Healthcare in the 1st quarter worth about $27,000. Ameriflex Group Inc. purchased a new stake in shares of HCA Healthcare in the second quarter worth about $27,000. Finally, Chung Wu Investment Group LLC bought a new position in shares of HCA Healthcare during the second quarter worth about $27,000. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.